Which treatment is indicated for candidal vulvovaginitis?

Candidal vulvovaginitis is a fungal infection caused by Candida species, most commonly Candida albicans. The treatment options for this condition typically aim to eradicate the overgrowth of yeast and restore normal vaginal flora.

Oral fluconazole is indicated for candidal vulvovaginitis as it is an effective antifungal medication that works systemically to inhibit the growth of fungi. This medication is particularly beneficial in treating moderate to severe infections or in cases where topical treatments are not appropriate or have failed. Fluconazole is usually taken as a single dose, making it a convenient treatment option.

Topical treatments, such as clotrimazole, are also effective for localized infections, but oral fluconazole is used in specific situations, such as recurrent infections or when compliance with topical therapies may be a concern. Thus, while topical options exist and can be effective, oral fluconazole provides a broader therapeutic approach, particularly in cases that may require a more aggressive or systemic intervention.

The other options, including topical steroids and intravaginal boric acid, are not standard treatments for candidal vulvovaginitis. Topical steroids can potentially worsen candidal infections by altering local immunity, and boric acid is not a primary